Topographical and cytopathological lesion analysis of the white matter in Binswanger?s disease brains
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The purpose of the present study was to document the topographical and cytopathological lesions in the white matter (WM) of Binswanger's disease (BD) brains. Subcortical WM lesions in each lobe and fiber bundle lesions related to the medial thalamic and hippocampal structures in clinicopathologically proven BD brains were evaluated by Klüver-Barrera staining using a grading score. Lesions in the frontal subcortical WM of BD brains, brains from non-neurological patients, and brains with cerebral hemorrhage or large cortical infarcts were also examined immunohistochemically using molecular markers for axonal flow damage: amyloid precursor protein (APP); and for demyelinating axonopathy: encephalitogenic peptide (EP). Our results indicated that the WM lesions in BD were significantly more prominent in the frontal periventricular and subcortical regions as compared with other subcortical WM lesions, in the order of the parietal, occipital and temporal lobes. Fiber bundle lesions in the capsular genu, including the anterior thalamic peduncle, were also significantly more prominent in BD brains as compared with the other bundle lesions. Furthermore, the frequency of damaged nerve fibers labeled by the EP antiserum and APP immunoreactive fibers was significantly higher in BD brains as compared with the control brains. The grading scores for the WM damage correlated significantly with those for the APP and EP immunoreactive fibers in all brains, including the control brains. The axonal damage in the frontal WM lesions of the BD brains was clearly revealed in our study using immunohistochemistry for APP and EP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most compelling support for the prevention of dementia by blood pressure lowering was observed in the Systolic Hypertension Europe (Syst-Eur) trial.442,449”
In the citing paper
“Dementia was diagnosed in 21 patients from the placebo group and 11 patients from the active treatment group, corresponding to a 50% (95% confidence interval 0% to 76%) decrease in the incidence of dementia in subjects receiving active treatment.”
In the citing paper
“All published trials share common limitations: (1) short follow-up duration442,444;”
In the citing paper
“However, 1 study reported a beneficial effect on the risk of dementia,442 and another reported an effect on the risk of PSD445”
Citations
Cites
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
Paramedian thalamic and midbrain infarcts: Clinical and neuropathological study
Castaigne, P., Lhermitte, F., Buge, A., Escourolle, R., Hauw, J. J., & Lyon‐Caen, O. (1981) · Annals of Neurology · doi:10.1002/ana.410100204 · Cited by 559
Senile Dementia of the Binswanger Type: A Vascular Form of Dementia in the Elderly
Román, G. C. (1987) · JAMA · doi:10.1001/jama.1987.03400130096040 · Cited by 372
Why do frontal lobe symptoms predominate in vascular dementia with lacunes?
Ishii, N., Nishihara, Y., & Imamura, T. (1986) · Neurology · doi:10.1212/wnl.36.3.340 · Cited by 293
Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging
Press, G. A., Amaral, D. G., & Squire, L. R. (1989) · Nature · doi:10.1038/341054a0 · Cited by 281
Confusion and memory loss from capsular genu infarction: A thalamocortical disconnection syndrome?
Tatemichi, T. K., Desmond, D. W., PhD, I. P., Cross, D. T., Gropen, T. I., Mohr, J. P., & PhD, Y. S. (1992) · Neurology · doi:10.1212/wnl.42.10.1966 · Cited by 278
Binswanger's disease--revisited
Caplan, L. R. (1995) · Neurology · doi:10.1212/wnl.45.4.626 · Cited by 227
Medullary arteries in aging and dementia.
Furuta, A., Ishii, N., Nishihara, Y., & Horie, A. (1991) · Stroke · doi:10.1161/01.str.22.4.442 · Cited by 185
Goto, K., Ishii, N., & Fukasawa, H. (1981) · Radiology · doi:10.1148/radiology.141.3.7302224 · Cited by 181
Bjartmar, C., Battistuta, J., Terada, N., Dupree, E., & Trapp, B. D. (2002) · Annals of Neurology · doi:10.1002/ana.10052 · Cited by 169
OLSZEWSKI, J. (1962) · PubMed · Cited by 161
Tomimoto, H., Ihara, M., Wakita, H., Ohtani, R., Lin, J.-X., Akiguchi, I., Kinoshita, M., & Shibasaki, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0749-3 · Cited by 159
Self-citationYamanouchi, H., & Nagura, H. (1997) · Stroke · doi:10.1161/01.str.28.5.965 · Cited by 145
Englund, E. M., & Brun, A. (1990) · Histopathology · doi:10.1111/j.1365-2559.1990.tb01542.x · Cited by 143
Alterations in Glia and Axons in the Brains of Binswanger’s Disease Patients
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1997) · Stroke · doi:10.1161/01.str.28.7.1423 · Cited by 142
Self-citationMyelin Degeneration in Multiple System Atrophy Detected by Unique Antibodies
Matsuo, A., Akiguchi, I., Lee, G. C., McGeer, E. G., McGeer, P. L., & Kimura, J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65617-9 · Cited by 130
Self-citationNeurocardiovascular Instability in Cognitive Impairment and Dementia
Kenny, R. A., Kalaria, R. N., & Ballard, C. G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04816.x · Cited by 111
Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050768 · Cited by 104
Self-citationDiagnosis and management of vascular cognitive impairment and dementia
Erkinjuntti, T. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6137-1_6 · Cited by 88
Révész, T., Hawkins, C. P., du Boulay, E. P., Barnard, R. O., & McDonald, W. I. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.12.1337 · Cited by 85
Yamamoto, Y., Akiguchi, I., Oiwa, K., Hayashi, M., Kasai, T., & Ozasa, K. (2002) · Stroke · doi:10.1161/str.33.1.297 · Cited by 84
Self-citationVascular Architecture in White Matter of Neonates
Nakamura, Y., Okudera, T., & Hashimoto, T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199411000-00005 · Cited by 71
Suenaga, T., Ohnishi, K., Nishimura, M., Nakamura, S., Akiguchi, I., & Kumura, J. (1994) · Acta Neuropathologica · doi:10.1007/bf00294171 · Cited by 56
Self-citationYamanouchi, H., Sugiura, S., & Tomonaga, M. (1989) · Journal of Neurology · doi:10.1007/bf00314894 · Cited by 54
IANOTA, I. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92217-0 · Cited by 23
Akiguchi, I., Ino, T., Nabatame, H., Udaka, F., Matsubayashi, K., Fukuyama, H., & Kameyama, M. (1987) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.26.15 · Cited by 22
Self-citationOhtani, R., Tomimoto, H., Yagi, H., Akiguchi, I., Shibasaki, H., & Kawasaki, T. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0996-1 · Cited by 11
Self-citationWatanabe, T., Akiguchi, I., YAGI, H., Onishi, K., KAWASAKI, T., Shiino, A., & Inubushi, T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04847.x · Cited by 10
Self-citationCytopathological alterations and therapeutic approaches in Binswanger's disease
Akiguchi, I., Tomimoto, H., Wakita, H., Yamamoto, Y., Suenaga, T., Ueno, M., & Budka, H. (1999) · Neuropathology · doi:10.1046/j.1440-1789.1999.00208.x · Cited by 8
Self-citation[Prevalence, incidence, and risk factors of vascular dementia: the Hisayama study].
Kiyohara, Y. (1999) · PubMed · Cited by 7
Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions
Tomimoto, H., Akiguchi, I., Matsuo, A., Terai, K., Wakita, H., Kimura, J., McGeer, P. L., & Budka, H. (1997) · Neuroreport · doi:10.1097/00001756-199712010-00014 · Cited by 5
Self-citationKitani, M., Tomonaga, M., Yoshimura, M., Mori, H., & Yamanouchi, H. (1986) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.23.155 · Cited by 1
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
“The possibility that the roposed myelin repair mechanism is generalized is suported by the apparent presence of these swellings in many ajor CNS disorders including traumatic brain injury (Uryu t al., 2007), multiple sclerosis (Aboul-Enein et al., 2006), nd ischemic damage (Akiguchi et al., 2004).”
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647
Ihara, M., Polvikoski, T. M., Hall, R., Slade, J. Y., Perry, R. H., Oakley, A. E., Englund, E., O’Brien, J. T., Ince, P. G., & Kalaria, R. N. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0635-8 · Cited by 244
“WM is preferentially vulnerable compared to the temporal WM during ageing and vascular disease [2, 41, 48].”
BackgroundKalaria, R. N. (2012) · Stroke · doi:10.1161/strokeaha.112.655803 · Cited by 227
Metadata
- Authors
- Akiguchi, I., Tomimoto, H., Wakita, H., Kawamoto, Y., Matsuo, A., Ohnishi, K., Watanabe, T., & Budka, H.
- Affiliations
- Kyoto University (JP)
- Takeda Hospital (JP)
- Medical University of Vienna (AT)
- Corresponding author
- Akiguchi, Ichiro
- Venue
- Acta Neuropathologica
- Published
- 2004-06-01
- Volume
- 107
- Issue
- 6
- Pages
- 563-570
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2034298815
- Cited by
- 25
- References
- 33
- Citations by year
- 2024: 1 · 2021: 3 · 2020: 1 · 2018: 1 · 2016: 1 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- Binswanger disease, white matter lesions, subcortical white matter, axonal injury, amyloid precursor protein, encephalitogenic peptides, Klüver-Barrera staining, cerebral small vessel disease, cerebral hemorrhage, cortical infarction
- MeSH terms
- Adult, Aged, Aged, 80 and over, Brain, Myelin Basic Protein, Female, Humans, Immunohistochemistry, Male, Middle Aged, Peptide Fragments, Dementia, Vascular, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.